Seeing Is Believing
Currently, out of the existing stock ratings of Lauren Chung - 3 which are a Buy (100%)
Analyst Lauren Chung works at JPMORGAN and is covering the Healthcare sector with 6 price targets and ratings displayed on 1 stocks.
Most recent stock forecast was given on ZYNE, Zynerba Pharmaceuticals at 28-Mar-2017.
Analyst best performing recommendations are on ZYNE (ZYNERBA PHARMACEUTICALS).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
1.11
$-0.19 (-14.62%)
3 months 13 days ago
0/1 (0%)
$-0.18 (-13.95%)
Hold
16
3 months 14 days ago
0/2 (0%)
$9.1 (50.70%)
Buy
8
$6.7 (515.38%)
2 years 6 months 23 days ago
2/5 (40%)
$3.76 (42.81%)
154
Buy
7.25
$5.95 (457.69%)
2 years 8 months 19 days ago
0/2 (0%)
$4.16 (81.92%)
Buy
3 years 4 months 28 days ago
0/1 (0%)
$9.43 (110.04%)
What Year was the first public recommendation made by Lauren Chung?